Anna Sarnefalt

Title: Anna Sarnefalt: Innovator in Monoclonal Antibody Research

Introduction

Anna Sarnefalt is a prominent inventor based in Malmö, Sweden. She has made significant contributions to the field of biomedical research, particularly in the development of human monoclonal antibodies. With a total of 3 patents to her name, her work focuses on innovative treatments for various inflammatory diseases.

Latest Patents

Among her latest patents, Anna has developed a method for the prophylaxis, improvement, or treatment of inflammatory bowel disease, multiple sclerosis, and psoriasis. This invention involves administering an effective amount of an isolated anti-human CD81 antibody that binds to a specific peptide region. Another notable patent provides an anti-CD81 antibody that can be utilized as a pharmaceutical product for humans, specifically targeting the same peptide region.

Career Highlights

Throughout her career, Anna has worked with reputable companies such as Sumitomo Dainippon Pharma Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective therapeutic solutions.

Collaborations

Anna has collaborated with esteemed colleagues in her field, including Takamasa Watanabe and Tadahiko Yoshima. These partnerships have further enriched her research and innovation efforts.

Conclusion

Anna Sarnefalt's work in monoclonal antibody research exemplifies her dedication to improving healthcare through innovative solutions. Her patents reflect her commitment to addressing significant medical challenges.